Andrei Onischuk

Dr. Andrei Onischuk


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in Journal of Aerosol Medicine and Pulmonary Drug Delivery
Verified
Journal Article
Closed access
AOAndrei Onischuk
Andrei Onischuk
TTTatyana G. Tolstikova
Tatyana G. Tolstikova
Irina Vasilievna SorokinaIrina Vasilievna Sorokina
Irina Vasilievna Sorokina
NZNatalya A. Zhukova
Natalya A. Zhukova
ABAnatoly M. Baklanov
Anatoly M. Baklanov
VFVasilii M. Fomin
Vasilii M. Fomin
Background: Aerosol lung administration is a convenient way to deliver water-insoluble or poorly soluble drugs, provided that small-sized particles are generated. Here, for the outbred male mice, we show that the pulmonary administration of ibuprofen nanoparticles requires a dose that is three to five orders of magnitude less than that for the orally delivered particles at the same analgesic effect. Method: The aerosol evaporation–condensation generator consisted of a horizontal cylindrical quartz tube with an outer heater. Argon flow was supplied to the inlet and aerosol was formed at the outlet. The particle mean diameter and number concentration varied from 10 to 100 nm and 103−107 cm−3, respectively. The analgesic action and side pulmonary effects caused by the inhalation of ibuprofen nanoparticles were investigated. Results: The chemical composition of aerosol particles was shown to be identical with the maternal drug. Using the nose-only exposure chambers, the mice lung deposition efficiency was evaluated as a function of the particle diameter. Conclusions: The dose-dependent analgesic effect of aerosolized ibuprofen was studied in comparison with the oral treatment. It was found that the dose for aerosol treatment is three to five orders of magnitude less than that required for oral treatment at the same analgesic effect. Accompanying effects were moderate venous hyperemia and some emphysematous signs.

17 April 2008 in Journal of Aerosol Medicine and Pulmonary Drug Delivery
Verified
Journal Article
Closed access
AOAndrei Onischuk
Andrei Onischuk
TTTatjana G. Tolstikova
Tatjana G. Tolstikova
Irina Vasilievna SorokinaIrina Vasilievna Sorokina
Irina Vasilievna Sorokina
NZNatalja A. Zhukova
Natalja A. Zhukova
ABAnatoly M. Baklanov
Anatoly M. Baklanov
VFVasilii M. Fomin
Vasilii M. Fomin
The respiratory system provides entry for drug nanoparticles to cure systemic diseases. The modern devices that are available on the market of therapeutic aerosol delivery systems have a number of disadvantages. There remains a need for an alternative means that is low cost, convenient, and capable of producing small-sized particles. On the other hand, one-third of the modern drugs are poorly water soluble. Many currently available injectable formulations of such drugs can cause side effects that originate from detergents and other agents used for their solubilization. The aerosol lung administration may by a good way for delivery of the water-insoluble drugs. We present here a new way for the generation of drug nanoparticles suitable for many water insoluble substances based on the evaporation–condensation route. In this paper the indomethacin nanoaerosol formation was studied and its anti-inflammatory effect to the outbred male mice was examined. The evaporation–condensation aerosol generator consisted of a horizontal cylindrical quartz tube with an outer heater. Argon flow was supplied to the inlet and the aerosol was formed at the outlet. The particle mean diameter and number concentration were varied in the ranges 3 to 200 nm and 10 3 to 10 7 cm −3 , respectively. The liquid chromatography and X-ray diffraction methods have shown the nanoparticles consist of the amorphous phase indomethacin. The aerosol lung administration experiments were carried out in the whole-body exposure chamber. Both the lung deposited dose and the particle deposition efficiency were determined as a function of the mean particle diameter for mice being housed into the nose-only exposure chambers. The anti-inflammatory action and side pulmonary effects caused by the inhalation of indomethacin nanoparticles were investigated. It was found that the aerosol administration was much more effective than the peroral treatment. The aerosol route required a therapeutic dose six orders of magnitude less than that for peroral administration.

24 October 2017 in Aerosol Science and Technology
Verified
Journal Article
Closed access
AOAndrei Onischuk
Andrei Onischuk
ABA. M. Baklanov
A. M. Baklanov
SVSergey Valiulin
Sergey Valiulin
PMP. P. Moiseenko
P. P. Moiseenko
VMV. G. Mitrochenko
V. G. Mitrochenko
A new algorithm is proposed for the determination of aerosol particle size distribution from a set of screen diffusion battery penetrations. The idea is to determine the size spectra of the fractions of particles separated by the sections of diffusion battery, so the total size distribution is the sum of the spectra of fractions. The spectrum of each fraction is approximated by the lognormal function, which is defined by two parameters: the standard geometric deviation (SGD) and geometric mean diameter. The SGD value is chosen to be 1.35 for each fraction. The geometric mean diameters of fractions are calculated from the diffusion battery penetrations. For this purpose, analytical formulas are derived to link the mean single-fiber collection efficiency for each fraction with the experimentally measured penetrations. Then the mean diameters of fractions are calculated from the collection efficiencies using the fan model filtration theory. To achieve a better size resolution, numerical approach is proposed to calculate the particle size spectrum using the analytical solution as an initial approximation. The validity of the analytical and numerical solutions is investigated by comparing them with the spectra determined by means of transmission electron microscopy and gravity settling. For this purpose, the aerosol is generated using the evaporation-nucleation technique, Collison-type nebulizer, and hot-wire bulb generator. It is found that the analytical solution demonstrates a good sizing accuracy but relatively poor size resolution, while the numerical approach results in both good sizing accuracy and good size resolution for the two-mode aerosol. Copyright © 2018 American Association for Aerosol Research

26 July 2018 in Aerosol Science and Technology
Verified
Journal Article
Closed access
AOAndrei Onischuk
Andrei Onischuk
SVSergey Valiulin
Sergey Valiulin
ABA. M. Baklanov
A. M. Baklanov
PMP. P. Moiseenko
P. P. Moiseenko
VMV. G. Mitrochenko
V. G. Mitrochenko
The algorithm of the analytical inversion of aerosol size distribution is proposed in this work. As the diffusion battery separates particles into several fractions according to their diffusivity, the total spectrum can be represented as the sum of spectra of fractions. Analytical formulas are derived to calculate mean diameters for particles in different fractions using diffusion battery penetrations as input parameters. The spectra of fractions are approximated by lognormal functions. Two analytical solutions for the aerosol size distribution inversion problem are discussed. The sizing accuracy of analytical solutions is investigated, comparing them with the measurements through transmission electron microscopy using the laboratory-generated NaCl aerosol. The agreement is demonstrated to be within 10% accuracy. It is shown that in case of two-mode size distribution, the spectrum components are well resolved for rather distant peaks (modal diameters of 10 and 300 nm) and poorly resolved for nearby modes (50 and 300 nm). To improve the peak resolution, the procedure of spectrum correction is applied demonstrating an excellent peak separation. Finally, the peak resolution is experimentally verified for the laboratory-generated two-mode spectra of tungsten oxide–NaCl aerosol with the modal diameters of 10 and 60 nm, respectively. Both analytical solutions demonstrated good peak resolution. Copyright © 2018 American Association for Aerosol Research

1 July 2016 in Journal of Aerosol Science
Verified
Journal Article
Closed access
AOAndrei Onischuk
Andrei Onischuk
SVSergey Valiulin
Sergey Valiulin
SVS.V. Vosel
S.V. Vosel
VKV.V. Karasev
V.V. Karasev
VZV.D. Zelik
V.D. Zelik
ABA.M. Baklanov
A.M. Baklanov

1 November 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
SVSergey Valiulin
Sergey Valiulin
AOAndrei Onischuk
Andrei Onischuk
ABAnatoly M. Baklanov
Anatoly M. Baklanov
SDSergey N. Dubtsov
Sergey N. Dubtsov
GDGalina Dultseva
Galina Dultseva
YSY. S. Schwartz
Y. S. Schwartz
The aerosol inhalation delivery of isoniazid in mice was investigated, and the specific activity of the aerosol form of isoniazid was studied with the mouse model of tuberculosis infection, the M. tuberculosis H37Rv strain. Aerosol delivery was performed using a laminar-flow horizontal nucleation chamber. The inhalation dose was measured in real-time mode using a diffusion aerosol spectrometer. The mean particle diameter was 0.6 ± 0.03 μm, and the inhalation dose was 5–9 mg/kg. Pharmacokinetic measurements were carried out in nose-only and whole-body chambers. Isoniazid concentration in blood serum and its mass in the lungs were measured as a function of time using high-performance liquid chromatography. Studies of the specific activity of aerosolized isoniazid reveal that treatment with the aerosol lead to the complete recovery of the experimental tuberculosis infection as early as after 28 days after the start of inhalation treatment, while in the animals from the group receiving isoniazid per-orally, sole revivable tuberculosis mycobacteria were detected. Histologic examinations show that only a few macrophagal (nonspecific) granulomas without mycobacteria were detected in the spleen after per-oral and aerosol treatment, the number of granulomas on the 28th day being three times smaller in the latter case. The results show that the developed technique of isoniazid aerosol inhalation may have clinical potential.